WALTHAM, Mass.--(BUSINESS WIRE)--Affinia Therapeutics (“Affinia”), an innovative gene therapy company with a pipeline of first-in-class and/or best-in-class adeno-associated virus (AAV) gene therapies ...
Data demonstrate dose‑dependent hearing rescue across multiple mouse modelsCAMBRIDGE, Mass.--(BUSINESS ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results